Neprology Division, Department of Internal Medicine, National Taiwan University Hospital BeiHu Branch, Taipei, Taiwan.
Geriatric and Community Medicine Research Center, National Taiwan University Hospital BeiHu Branch, Taipei, Taiwan.
Cardiovasc Diabetol. 2021 Apr 24;20(1):86. doi: 10.1186/s12933-021-01279-6.
Chronic kidney disease (CKD) introduces an increased cardiovascular risk among patients with diabetes mellitus (DM). The risk and tempo of cardiovascular diseases may differ depending upon their type. Whether CKD differentially influences the risk of developing each cardiovascular morbidity in patients with newly diagnosed DM remains unexplored.
We identified patients with incident DM from the Longitudinal Cohort of Diabetes Patients (LCDP) cohort (n = 429,616), and uncovered those developing CKD after DM and their propensity score-matched counterparts without. After follow-up, we examined the cardiovascular morbidity-free rates of patients with and without CKD after DM, followed by Cox proportional hazard regression analyses. We further evaluated the cumulative risk of developing each outcome consecutively during the study period.
From LCDP, we identified 55,961 diabetic patients with CKD and matched controls without CKD. After 4.2 years, patients with incident DM and CKD afterward had a significantly higher risk of mortality (hazard ratio [HR] 1.1, 95% confidence interval [CI] 1.06-1.14), heart failure (HF) (HR 1.282, 95% CI 1.19-1.38), acute myocardial infarction (AMI) (HR 1.16, 95% CI 1.04-1.3), and peripheral vascular disease (PVD) (HR 1.277, 95% CI 1.08-1.52) compared to those without CKD. The CKD-associated risk of mortality, HF and AMI became significant soon after DM occurred and remained significant throughout follow-up, while the risk of PVD conferred by CKD did not emerge until 4 years later. The CKD-associated risk of ischemic, hemorrhagic stroke and atrial fibrillation remained insignificant.
The cardiovascular risk profile among incident DM patients differs depending on disease type. These findings can facilitate the selection of an optimal strategy for early cardiovascular care for newly diagnosed diabetic patients.
慢性肾脏病(CKD)会增加糖尿病(DM)患者的心血管风险。不同类型的糖尿病患者发生心血管疾病的风险和速度可能有所不同。CKD 是否会对新诊断为 DM 的患者发生每种心血管疾病的风险产生不同影响,目前仍不清楚。
我们从纵向糖尿病患者队列(LCDP)队列中确定了患有新诊断 DM 的患者(n=429616),并发现了这些患者在 DM 后发生 CKD 以及他们的倾向评分匹配的无 CKD 患者。在随访之后,我们检查了 DM 后有和无 CKD 的患者的心血管疾病无事件生存率,随后进行 Cox 比例风险回归分析。我们还进一步评估了在研究期间每个结果连续发生的累积风险。
从 LCDP 中,我们确定了 55961 例患有 CKD 的糖尿病患者和无 CKD 的匹配对照者。在 4.2 年后,随后发生 DM 和 CKD 的患者死亡风险显著升高(风险比 [HR] 1.1,95%置信区间 [CI] 1.06-1.14)、心力衰竭(HF)(HR 1.282,95% CI 1.19-1.38)、急性心肌梗死(AMI)(HR 1.16,95% CI 1.04-1.3)和外周血管疾病(PVD)(HR 1.277,95% CI 1.08-1.52)。与无 CKD 的患者相比。DM 发生后不久,CKD 相关的死亡、HF 和 AMI 风险变得显著,并且在整个随访过程中保持显著,而 CKD 引起的 PVD 风险直到 4 年后才出现。CKD 相关的缺血性、出血性中风和心房颤动风险仍然不显著。
新诊断为 DM 的患者的心血管风险特征因疾病类型而异。这些发现可以为新诊断的糖尿病患者早期心血管护理选择最佳策略提供帮助。